Article Information
History
- May 1, 2024.
Article Versions
- Version 1 (July 28, 2023 - 10:37).
- Version 2 (October 6, 2023 - 09:25).
- Version 3 (October 23, 2023 - 13:19).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Wenfeng Ma1,2,3,4,
- Jinrong Huang2,
- Benqiang Cai1,4,
- Mumin Shao6,7,
- Xuewen Yu6,7,
- Mikkel Breinholt Kjær5,8,
- Minling Lv1,4,
- Xin Zhong1,4,
- Shaomin Xu1,4,
- Bolin Zhan1,4,
- Qun Li1,4,
- Qi Huang1,4,
- Mengqing Ma1,4,
- Lei Cheng2,
- Yonglun Luo2,3,*,
- Henning Grønæk5,*,
- Xiaozhou Zhou1,4,* and
- Lin Lin2,3,*
- 1Department of Liver Disease, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong 518033, China
- 2Department of Biomedicine, Aarhus University, Aarhus, Denmark
- 3Steno Diabetes Center Aarhus, Aarhus University Hospital, Aarhus, Denmark
- 4Department of Liver Disease, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518033, China
- 5Department of Hepatology and Gastroenterology, Aarhus University Hospital, Aarhus, Denmark
- 6Department of Pathology, Shenzhen Traditional Chinese Medicine Hospital, Shenzhen, Guangdong 518033, China
- 7Department of Pathology, The Fourth Clinical Medical College of Guangzhou University of Chinese Medicine, Shenzhen, 518033, China
- 8Department of Clinical Medicine, Aarhus University, Aarhus, Denmark
- ↵*corresponding author, email: henning.gronbaek{at}clin.au.dk
Posted May 01, 2024.
A gene-based clustering approach reveals QSOX1/IL1RAP as promising biomarkers for the severity of non-alcoholic fatty liver disease
